BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 16950020)

  • 1. Chapter 8: Screening for cervical cancer in developing countries.
    Denny L; Quinn M; Sankaranarayanan R
    Vaccine; 2006 Aug; 24 Suppl 3():S3/71-7. PubMed ID: 16950020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of screening and preventive strategies for cervical cancer in India.
    Patro BK; Nongkynrih B
    Indian J Public Health; 2007; 51(4):216-21. PubMed ID: 18232160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low cost methods for secondary prevention of cervical cancer in developing countries.
    Anorlu RI; Ola ER; Abudu OO
    Niger Postgrad Med J; 2007 Sep; 14(3):242-6. PubMed ID: 17767211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cancer in the developing world.
    Zeferino LC; Derchain SF
    Best Pract Res Clin Obstet Gynaecol; 2006 Jun; 20(3):339-54. PubMed ID: 16563869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
    Sankaranarayanan R; Budukh AM; Rajkumar R
    Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organization of screening programs in developing countries with reference to screening for cancer of the uterine cervix in India.
    Luthra UK; Rengachari R
    IARC Sci Publ; 1986; (76):273-88. PubMed ID: 3570411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytological screening for cervical cancer prevention.
    Denny L
    Best Pract Res Clin Obstet Gynaecol; 2012 Apr; 26(2):189-96. PubMed ID: 22071306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer screening in the 21st century: is it time to retire the PAP smear?
    Wright TC
    Clin Obstet Gynecol; 2007 Jun; 50(2):313-23. PubMed ID: 17513921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating human papillomavirus vaccination in cervical cancer control programmes.
    Franco EL; Coutlée F; Ferenczy A
    Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV testing for cervical cancer screening in Croatia.
    Grce M; Grahovac B; Rukavina T; Vrdoljak-Mozetic D; Glavas-Obrovac L; Kaliterna V; Zele-Starcević L
    Coll Antropol; 2007 Apr; 31 Suppl 2():67-71. PubMed ID: 17598507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Objective screening for cervical cancer in developing nations: lessons from Nigeria.
    Roblyer D; Richards-Kortum R; Park SY; Adewole I; Follen M
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S94-7. PubMed ID: 17825396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer prevention for all the world's women: genuine promise resides in skilled quality management rather than novel screening approaches.
    Suba EJ; Donnelly AD; Furia LM; Huynh ML; Raab SS;
    Diagn Cytopathol; 2007 Mar; 35(3):187-91. PubMed ID: 17304532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chapter 10: New dimensions in cervical cancer screening.
    Cuzick J; Mayrand MH; Ronco G; Snijders P; Wardle J
    Vaccine; 2006 Aug; 24 Suppl 3():S3/90-7. PubMed ID: 16950022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papanicolaou screening in developing countries: an idea whose time has come.
    Suba EJ; Raab SS;
    Am J Clin Pathol; 2004 Mar; 121(3):315-20. PubMed ID: 15023034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New technologies in cervical cancer screening.
    Gravitt PE; Coutlée F; Iftner T; Sellors JW; Quint WG; Wheeler CM
    Vaccine; 2008 Aug; 26 Suppl 10():K42-52. PubMed ID: 18847556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in the cumulative incidence rate of cervical cancer by one life time selective screening.
    Juneja A; Murthy NS; Tuteja RK; Sardana S; Das DK
    Neoplasma; 1997; 44(4):272-4. PubMed ID: 9473783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for cervical cancer prevention in Asia Pacific.
    Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
    Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer: screening and therapeutic perspectives.
    Sankaranarayanan R; Thara S; Esmy PO; Basu P
    Med Princ Pract; 2008; 17(5):351-64. PubMed ID: 18685274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crossing the quality chasm: a requirement for successful cervical cancer prevention in developing countries.
    Suba EJ
    Clin Lab Med; 2004 Dec; 24(4):945-63. PubMed ID: 15555750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.